C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades

Digestive and Liver Disease

Volumn 45, Issue 10, 2013, Pages 844-851

  Shi, Yi Chao ^a   Zhao, Hong ^b   Yin, Chuan ^a   Zeng, Xin ^a   Zhang, Qing ^a   Xu, Wen Ping ^a   Wei, Ji ^a   Chen, Fei ^a   Xie, Wei Fen ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

C EBP ; Hepatocellular carcinoma; Hes1; Notch3

Indexed keywords

ADENOVIRUS VECTOR; CCAAT ENHANCER BINDING PROTEIN ALPHA; NOTCH3 RECEPTOR; PROTEIN P27; TRANSCRIPTION FACTOR HES 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CONTROLLED STUDY; FIBROBLAST; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR XENOGRAFT; VIRUS RECOMBINANT;

C/EBPΑ; HEPATOCELLULAR CARCINOMA; HES1; NOTCH3;

ADENOVIRIDAE; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, HEPATOCELLULAR; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HOMEODOMAIN PROTEINS; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84883746123     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.03.013     Document Type: Article

References (34)

1. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
2. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
3. Schrem H., Klempnauer J., Borlak J. Liver-enriched transcription factors in liver function and development. Part I. The hepatocyte nuclear factor network and liver-specific gene expression. Pharmacological Reviews 2002, 54:129-158.
4. Yue H.Y., Yin C., Hou J.L., et al. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats. Gut 2010, 59:236-246.
5. Ning B.F., Ding J., Yin C., et al. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Research 2010, 70:7640-7651.
6. Zeng X., Lin Y., Yin C., et al. Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice. Hepatology 2011, 54:2036-2047.
7. Yin C., Lin Y., Zhang X., et al. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. Hepatology 2008, 48:1528-1539.
8. Ramji D.P., Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochemical Journal 2002, 365:561-575.
9. Schrem H., Klempnauer J., Borlak J. Liver-enriched transcription factors in liver function and development. Part II. The C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacological Reviews 2004, 56:291-330.
10. Watkins P.J., Condreay J.P., Huber B.E., et al. Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein. Cancer Research 1996, 56:1063-1067.
11. Wang G.L., Iakova P., Wilde M., et al. Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity. Genes and Development 2004, 18:912-925.
12. Lu G.D., Leung C.H.W., Yan B., et al. C/EBPα is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation. Gastroenterology 2010, 139. 632.e4-43.e4.
13. Nickoloff B.J., Osborne B.A., Miele L. Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents. Oncogene 2003, 22:6598-6608.
14. Bolos V., Grego-Bessa J., de la Pompa J.L. Notch signaling in development and cancer. Endocrine Reviews 2007, 28:339-363.
15. Sang L., Roberts J.M., Coller H.A. Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells. Trends in Molecular Medicine 2010, 16:17-26.
16. Jarriault S., Brou C., Logeat F., et al. Signalling downstream of activated mammalian Notch. Nature 1995, 377:355-358.
17. Kohler C., Bell A.W., Bowen W.C., et al. Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regeneration. Hepatology 2004, 39:1056-1065.
18. Ning L., Wentworth L., Chen H., et al. Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma. American Journal of Translational Research 2009, 1:358-366.
19. Wang X.Q., Zhang W., Lui E.L., et al. Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma. International Journal of Cancer 2012, 131:E163-E172.
20. Yang L., Jiang Y., Wu S.F., et al. CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction. Carcinogenesis 2008, 29:291-298.
21. Gulino A., Di Marcotullio L., Screpanti I. The multiple functions of Numb. Experimental Cell Research 2010, 316:900-906.
22. Kuo C.F., Xanthopoulos K.G., Darnell J.E. Fetal and adult localization of C/EBP: evidence for combinatorial action of transcription factors in cell-specific gene expression. Development 1990, 109:473-481.
23. Flodby P., Liao D.Z., Blanck A., et al. Expression of the liver-enriched transcription factors C/EBP alpha, C/EBP beta, HNF-1, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver. Molecular Carcinogenesis 1995, 12:103-109.
24. Wang G.L., Shi X., Haefliger S., et al. Elimination of C/EBPalpha through the ubiquitin-proteasome system promotes the development of liver cancer in mice. Journal of Clinical Investigation 2010, 120:2549-2562.
25. Mazzocca A., Fransvea E., Dituri F., et al. Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma. Hepatology 2010, 51:523-534.
26. Ishiyama T., Kano J., Minami Y., et al. Expression of HNFs and C/EBP alpha is correlated with immunocytochemical differentiation of cell lines derived from human hepatocellular carcinomas, hepatoblastomas and immortalized hepatocytes. Cancer Science 2003, 94:757-763.
27. Kodama Y., Hijikata M., Kageyama R., et al. The role of notch signaling in the development of intrahepatic bile ducts. Gastroenterology 2004, 127:1775-1786.
28. Wang T., You N., Tao K., et al. Notch is the key factor in the process of fetal liver stem/progenitor cells differentiation into hepatocytes. Development Growth and Differentiation 2012, 54:605-617.
29. Gramantieri L., Giovannini C., Lanzi A., et al. Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. Liver International 2007, 27:997-1007.
30. Giovannini C., Lacchini M., Gramantieri L., et al. Notch3 intracellular domain accumulates in HepG2 cell line. Anticancer Research 2006, 26:2123-2127.
31. Giovannini C., Gramantieri L., Chieco P., et al. Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism. Journal of Hepatology 2009, 50:969-979.
32. Iakova P., Awad S.S., Timchenko N.A. Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest. Cell 2003, 113:495-506.
33. Cram E.J., Ramos R.A., Wang E.C., et al. Role of the CCAAT/enhancer binding protein-alpha transcription factor in the glucocorticoid stimulation of p21waf1/cip1 gene promoter activity in growth-arrested rat hepatoma cells. Journal of Biological Chemistry 1998, 273:2008-2014.
34. Zeng C., Wang R., Li D., et al. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma. Hepatology 2010, 52:1702-1712.